Among the various positive human cancers TSPY expression is the highest in hepatocellular carcinoma (HCC) (33%), followed by lung adenocarcinoma (17%), head and neck cancer (11%), bladder cancer (10%), and kidney cancer (6%). This evidence concerns the gene TSPY1 and hepatocellular carcinoma.